• CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources


  • 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsGAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    Rescheduled, so you won't miss a thing! Find out what to do next!

    April 20-24, 2021, Honolulu, Hawaii

    More Information

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations! (EXTENDED DEADLINE)

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2020-21 National Board of Directors? Register online NOW by March 31, 2020!

    Step Up - NOW is the Time! Register Here>

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2020.

    Get started... nominate today!

Several Risk Factors Point to the Use of High-Risk Medications in Older Veterans

Certain medications are not appropriate for the elderly and may cause more harm than good.

These include certain antihistamines, analgesics, muscle relaxants, psychotropics, and cardiac medications. A list of these medications has been established by the National Committee on Quality Assurance to be used as a benchmark by Medicare and other managed care plans.

Although use of these high-risk medications showed a modest decline between 2003 and 2006, some medications rose in usage.

Researchers retrospectively looked at medication use by 1,567,467 veterans 65 years of age and older, who received care from 2003 to 2006 from outpatient clinics run by the Department of Veterans Affairs.

The veterans’ exposure to these high-risk medications decreased from 13.1% in 2004 to 12.3% in 2006. Significant reductions were found for opioid pain relievers, muscle relaxants, psychotropics, endocrine medications, cardiac drugs, and vasodilator medications.

However, relative increases were discovered for amphetamines (10.3%), and ketorolac (8%).

A statistically significant increase in exposure was also found for the antibiotic nitrofurantoin (36.5%). Patients more likely to be exposed to these high-risk medications were female, Hispanic, took a higher number of medications, had a co-existing psychiatric problem, and had a high use of primary care.

For more info, see Pugh et al. (2011). Trends in use of high-risk medications for older veterans: 2004 to 2006. Journal of the American Geriatrics Society, 59(10),  1891-1898.

Related Topic 1: 

GAPNA Newsletter Issue: